Tagrisso has been approved in the United States for adjuvant treatment of adults patients diagnosed early enough for the tumor to be surgically removed, and who have a mutation of the EGFR gene, AstraZeneca said.
AstraZeneca's Tagrisso gets broader US approval for lung cancer
By REUTERS
04/26/2024 02:13 PM
By REUTERS
04/26/2024 01:09 PM
By REUTERS
04/26/2024 07:54 AM
By REUTERS
04/26/2024 12:12 AM